SequelSEC

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ

Biological Products, (No Diagnostic Substances) · CIK 0001187953 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$3.00K
Fiscal year ended 2026-06-30
Operating income
-$6.24M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) reported revenue of $3.00K and net income of -$6.04M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).

Income

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$3.00K
Cost of revenue$994
Gross profit$2.01K
Operating income-$6.24M
Net income-$6.04M
Research & development$2.02M
Weighted-average diluted sharesUnavailable
Pretax income-$6.04M
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrative$4.11M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$9.38M
Current assets$9.02M
Total liabilities$698.60K
Current liabilities$698.60K
Total equity incl. NCI$8.68M
Temporary (mezzanine) equityUnavailable
Inventory$125.00K
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$684.40K

Cash flow

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$5.90M
Capital expendituresUnavailable
Investing cash flow-$225.50K
Financing cash flow$8.30M
Net change in cashUnavailable
Stock-based compensation$0
Common dividends paidUnavailable
Common share repurchases$0
Depreciation & amortizationUnavailable

Derived

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin66.9%
Operating margin-208004.4%
FCF marginUnavailable
SBC / revenue0.0%
Current ratio12.91x
Revenue YoY growth-50.0%
Net margin-201355.4%
R&D / revenue67203.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CELZ in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-03-20View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

ABOS ABPO ACOG ADAPY ADMA ADPT AGEN AGTX AIM ALEC ALGS ALLO

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.